Leadership

Edward S. Guindi, M.D.
President and CEO

Dr. Guindi is the founder of CORD:USE, has overall responsibility for the company and is focused upon building its world-class team, its hospital network and its relationships with obstetricians. CORD:USE is the culmination of Dr. Guindi’s direct experience as a highly successful obstetrician, his intensive study of the cord blood banking field and his ability to assemble a world-class team. Prior to starting CORD:USE, Dr. Guindi was a fully licensed practicing physician, board-certified in Obstetrics and Gynecology. Dr. Guindi received his Doctor of Medicine degree from Wayne State University School of Medicine in Detroit, Michigan. He is a member of the National Marrow Donor Program (“NMDP”) Cord Blood Committee.

Back to Top



Michael T. Ernst

Executive Vice President and Chief Financial Officer

Mr. Ernst is the co-founder of CORD:USE and has responsibility for the administration of the company’s operations, capital, finances and contractual relationships. He is highly experienced in building, advising and financing businesses, spanning developmental companies through mature global industry leaders. Mr. Ernst enjoyed a successful 19 year corporate and investment banking career and, most recently, was a Managing Director with Banc of America Securities. Mr. Ernst served on the Board of Directors for two affiliates of the Swiss Re Group. Mr. Ernst received his MBA from University of Chicago and his BA from Denison University.

Back to Top




Thomas Moss
Vice President

Mr. Moss has 20 years of experience in both blood and cord blood banking. Prior to joining CORD:USE, he was the Director of Operations for the cord blood program of the New York Blood Center. Other appointments include the Hoxworth Blood Center of the University of Cincinnati and ViaCell, Inc. Mr. Moss is very experienced in creating and maintaining efficient, high quality operations in FDA regulated environments. At CORD:USE, he is responsible for the CORD:USE Collection Network, administration of quality programs and maintaining regulatory compliance. Mr. Moss received his BS from Marietta College.

Back to Top




Joanne Kurtzberg, M.D.
Medical Director, CORD:USE Cord Blood Bank at Duke

Dr. Kurtzberg is the Director of the Pediatric Blood and Marrow Program and Professor of Pediatrics and Pathology at Duke University. She is a pioneer in the field of cord blood stem cell transplantation having performed the first unrelated cord blood stem cell transplant in 1993. Since this transplant, she and her team have performed approximately 1000 umbilical cord blood transplants and have performed more transplants in children than any other program worldwide. Dr. Kurtzberg is widely published and a frequent speaker for hematopoietic transplantation. Dr. Kurtzberg is the Co-Chair of the Cord Blood Advisory Group of the NMDP and a member of the HRSA Advisory Council on Blood Stem Cell Transplantation.

Back to Top



Alan S. Levine, Ph.D.
Chief Scientific Officer

Prior to joining CORD:USE, Dr. Levine had a highly successful 25 year career with the National Institutes of Health, where he was most recently the Director of the Blood Disease Program of the National Heart, Lung, and Blood Institute (“NHLBI”). In this capacity, Dr. Levine was responsible for initiating the bone marrow and umbilical cord blood transplant programs at the NHLBI. He has received numerous honors and awards in recognition of his success in directing national multicenter programs in hematology research. Dr. Levine received his Ph.D. in chemistry from the University of Delaware and his B. S. from Monmouth University.

Back to Top



Hal E. Broxmeyer, Ph.D.
Member, Medical and Scientific Advisory Board

Dr. Broxmeyer a Distinguished Professor, Indiana University; Professor, Microbiology and Immunology, Mary Margaret Walther Professor Emeritus, former Scientific Director of the Walther Oncology Center, and former Chairman of the Department of Microbiology and Immunology, Indiana University School of Medicine. Dr. Broxmeyer is recognized as a founder of the field of cord blood stem cell transplantation. He has authored over 600 publications and is on 10 scientific editorial boards. Dr. Broxmeyer has won numerous awards including the E. Donnall Thomas Award from the American Society of Hematology (“ASH”). He is the 2010 President of ASH and is a member of the HRSA Advisory Council on Blood Stem Cell Transplantation.

Back to Top




John Wagner, M.D.
Member, Medical and Scientific Advisory Board

Dr. Wagner is the Division Director of the Hematology-Oncology and Blood and Marrow Transplantation Program, the Scientific Director of Clinical Research of the Stem Cell Institute and the Scientific Director of Molecular and Cellular Therapeutics and the Clinical Trials Office of the NCI designated Cancer Center at the University of Minnesota. Dr. Wagner has authored more than 180 publications on hematopoietic stem cell transplantation, co-chairs the Committee on Alternative Stem Cell Sources of the International Bone Marrow Transplant Registry and has served on the Board of Directors of the NMDP since January 2002. Dr. Wagner played a key role in the development of double cord blood transplants.

Back to Top



Eliane Gluckman, M.D., Ph.D.
Member, Medical and Scientific Advisory Board

Dr. Gluckman is a Professor of Hematology at University of Paris VII. She is the head of the International Registry on Cord Blood Transplantation, EuroCord, at the Hospital Saint Louis APHP and President of the European School of Hematology. Dr. Gluckman is a founding member and former president of the European Group of Bone Marrow Transplantation (EBMT) and has authored over 700 publications. She performed the world’s first successful cord blood transplant (sibling donor) in 1988. During her 30 years as a transplanter, Dr. Gluckman has performed over 1900 bone marrow and cord blood transplants.

Back to Top



Carolyn M. Bechtel
Director, CORD:USE Foundation

Ms. Bechtel has led the formative operations of the CORD:USE Foundation and has been responsible for its processes to date. She has served on the Duke Comprehensive Cancer Center Board of Overseers for the past 19 years and has also been involved with many programs which support children with life-threatening diseases including the Victory Junction Gang Camp (a Paul Newman Hole In The Wall Gang Camp).

Back to Top





Stephen Sprague
Director, Patient Advocacy

Mr. Sprague was diagnosed thirteen years ago with CML and became one of the initial adult patients to benefit from a cord blood transplant in 1997. Since his transplant, he has been cancer free and has become an avid “Cord Blood Crusader,” sharing his unique message of hope and encouragement with thousands of patients, families and caregivers. The published accounts of his transplant experiences have been frequently cited, and he is often asked to testify in Washington in support of cord blood stem cell therapies. Mr. Sprague is a member of the HRSA Advisory Council on Blood Stem Cell Transplantation.

Back to Top